These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32429862)

  • 1. Multivariate joint modeling to identify markers of growth and lung function decline that predict cystic fibrosis pulmonary exacerbation onset.
    Andrinopoulou ER; Clancy JP; Szczesniak RD
    BMC Pulm Med; 2020 May; 20(1):142. PubMed ID: 32429862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosis.
    Li D; Keogh R; Clancy JP; Szczesniak RD
    Emerg Themes Epidemiol; 2017; 14():13. PubMed ID: 29201130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
    Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
    J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
    Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
    Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid lung function decline in adults with early-stage cystic fibrosis lung disease.
    Dasenbrook EC; Fink AK; Schechter MS; Sanders DB; Millar SJ; Pasta DJ; Mayer-Hamblett N
    J Cyst Fibros; 2020 Jul; 19(4):527-533. PubMed ID: 31870629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis.
    Zemel BS; Kawchak DA; Cnaan A; Zhao H; Scanlin TF; Stallings VA
    Pediatr Res; 1996 Oct; 40(4):578-86. PubMed ID: 8888286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.
    Steinkamp G; Wiedemann B
    Thorax; 2002 Jul; 57(7):596-601. PubMed ID: 12096202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients.
    Wojewodka G; De Sanctis JB; Bernier J; Bérubé J; Ahlgren HG; Gruber J; Landry J; Lands LC; Nguyen D; Rousseau S; Benedetti A; Matouk E; Radzioch D
    PLoS One; 2014; 9(2):e88567. PubMed ID: 24533110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for lung disease progression in children with cystic fibrosis.
    van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis.
    Solem CT; Vera-Llonch M; Liu S; Botteman M; Castiglione B
    Health Qual Life Outcomes; 2016 Apr; 14():63. PubMed ID: 27097977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.
    Szczesniak RD; McPhail GL; Duan LL; Macaluso M; Amin RS; Clancy JP
    Ann Epidemiol; 2013 Dec; 23(12):771-7. PubMed ID: 24103586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.
    Stahl M; Wielpütz MO; Graeber SY; Joachim C; Sommerburg O; Kauczor HU; Puderbach M; Eichinger M; Mall MA
    Am J Respir Crit Care Med; 2017 Feb; 195(3):349-359. PubMed ID: 27575911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.
    Britton LJ; Oates GR; Oster RA; Self ST; Troxler RB; Hoover WC; Gutierrez HH; Harris WT
    Pediatr Pulmonol; 2016 Nov; 51(11):1168-1176. PubMed ID: 27556254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of Disease Progression and Gastrostomy Tube Placement in Children and Adolescents with Cystic Fibrosis: Application of Joint Models for Longitudinal and Time-to-Event Data.
    Szczesniak R; Su W; Clancy JP
    Intern Med Rev (Wash D C); 2016 Oct; 2(9):. PubMed ID: 28232958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of mortality in adolescents with cystic fibrosis.
    Hulzebos EH; Bomhof-Roordink H; van de Weert-van Leeuwen PB; Twisk JW; Arets HG; van der Ent CK; Takken T
    Med Sci Sports Exerc; 2014 Nov; 46(11):2047-52. PubMed ID: 24848493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis.
    Vermeulen F; Proesmans M; Boon M; Havermans T; De Boeck K
    Thorax; 2014 Jan; 69(1):39-45. PubMed ID: 24021874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.
    Morgan WJ; Wagener JS; Yegin A; Pasta DJ; Millar SJ; Konstan MW; ;
    J Pediatr; 2013 Oct; 163(4):1152-7.e2. PubMed ID: 23810128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.
    Sanders DB; Fink A; Mayer-Hamblett N; Schechter MS; Sawicki GS; Rosenfeld M; Flume PA; Morgan WJ
    J Pediatr; 2015 Nov; 167(5):1081-8.e1. PubMed ID: 26340874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.